Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  gallium nitrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 51 for your search:
Start Over
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Gallium Nitrate for Bone Involvement from Breast Cancer (Summary Last Modified 02/98)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SP-BC-01, NCI-V96-0813
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Gallium Nitrate for Bone Involvement from Multiple Myeloma (Summary Last Modified 02/98)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SP-MM-01, NCI-V96-0814
Phase III Randomized, Double-Blind Study of Gallium Nitrate vs Disodium Pamidronate (APD) in Patients with Cancer-Related Hypercalcemia (Summary Last Modified 03/90)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FRE-IGR-T89-0069, NCI-T89-0069A, T89-0069
Phase III Randomized Comparison of Gallium Nitrate vs Etidronate in the Treatment of Cancer-Related Hypercalcemia (Summary Last Modified 09/87)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8733, NCI-T87-0085C, T87-0085
Phase III Randomized Study of Adjuvant Therapy with Gallium Nitrate for Bone Loss in Patients with Multiple Myeloma (Summary Last Modified 05/89)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8735, NCI-T87-0089H, T87-0089
Phase I/II Study of Continuous-Infusion GAN for Hormone-Refractory Metastatic Prostate Cancer (Summary Last Modified 10/95)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-94-C-0207A, NCI-T94-0095N, T94-0095
Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: DS 96-26, RPCI-DS-96-26, UTHSC-9235011358, NCI-T94-0043D, T94-0043, NCT00002578
Phase II Chemotherapy with Gallium Nitrate for Advanced Hodgkin's Disease and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-81107
Phase II Chemotherapy with Gallium Nitrate for Incurable Advanced Soft Tissue and Bone Sarcomas
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7911
Phase II Study of Gallium Nitrate for Hodgkin's and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7912
Phase II Chemotherapy with Gallium Nitrate in Previously Treated Patients with Metastatic Breast Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7917
Phase II Chemotherapy with Gallium Nitrate for Metastatic or Locally Recurrent Squamous Cell Carcinoma of the Head & Neck
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7923
Phase II Chemotherapy with Gallium Nitrate for Previously Untreated Recurrent or Metastatic Carcinoma of the Colon or Rectum
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7940/43
Phase II Pilot Gallium Nitrate for the Treatment of Cancer-Related Hypercalcemia
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor:
Protocol IDs: MSKCC-82100C, NCI-W82-1435, W82-1435
Phase II Pilot Chemotherapy with Gallium Nitrate/VP-16/MeGAG for Advanced, Refractory non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor:
Protocol IDs: MSKCC-82137B
Phase II Chemotherapy with Gallium Nitrate for Advanced Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-82138, NCI-C83-0464
Phase II Chemotherapy with Gallium Nitrate for Refractory Multiple Myeloma and Related Plasma Cell Dyscrasias
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: MSKCC-8344, NCI-T83-1093D, T83-1093
Phase II Chemotherapy with Gallium Nitrate in Refractory non-Hodgkin's Lymphoma, Hodgkin's Disease, and Chronic Lymphocytic Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SEG-79RLPD267
Phase II Chemotherapy with Gallium Nitrate for Patients with Multiple Myeloma Refractory to Standard Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: SEG-MM-82292
Phase II Chemotherapy with Gallium Nitrate for Metastatic Malignancies of the Testes, Bladder, Prostate, and Kidney
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7916
Phase II Master Protocol for New Agents in the Treatment of Refractory Lymphoma --- GAN/VM-26 for non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-82143
Phase II Chemotherapy with Gallium Nitrate for Advanced, Hormone-Resistant Adenocarcinoma of the Prostate
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8394, NCI-T83-1211C, T83-1211
Phase II Chemotherapy with Continuous Infusion Gallium Nitrate in Adults with Refractory Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: UCHSC-GN-1, NCI-T84-0335D, T84-0335
Phase II Chemotherapy with Gallium Nitrate in Men with Refractory Germ Cell Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-208
Start Over